Biotinylation enhances the anticancer effects of 15d‑PGJ2 against breast cancer cells.

Saved in:
Bibliographic Details
Title: Biotinylation enhances the anticancer effects of 15d‑PGJ2 against breast cancer cells.
Authors: Colin C; Université de Lorraine, CNRS, CRAN, F-54000 Nancy, France., Meyer M; Université de Lorraine, CNRS, L2CM, F-54000 Nancy, France., Cerella C; Laboratory for Molecular and Cellular Biology of Cancer, Kirchberg Hospital, L‑2540 Luxembourg, Luxembourg., Kleinclauss A; Université de Lorraine, CNRS, CRAN, F-54000 Nancy, France., Monard G; Université de Lorraine, CNRS, LPCT, F-54000 Nancy, France., Boisbrun M; Université de Lorraine, CNRS, L2CM, F-54000 Nancy, France., Diederich M; Department of Pharmacy, College of Pharmacy, Seoul National University, Seoul 151‑742, Republic of Korea., Flament S; Université de Lorraine, CNRS, CRAN, F-54000 Nancy, France., Grillier-Vuissoz I; Université de Lorraine, CNRS, CRAN, F-54000 Nancy, France., Kuntz S; Université de Lorraine, CNRS, CRAN, F-54000 Nancy, France.
Source: International journal of oncology [Int J Oncol] 2018 Jun; Vol. 52 (6), pp. 1991-2000. Date of Electronic Publication: 2018 Mar 28.
Publication Type: Comparative Study; Journal Article
Journal Info: Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9306042 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-2423 (Electronic) Linking ISSN: 10196439 NLM ISO Abbreviation: Int J Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1791-2423
DOI:10.3892/ijo.2018.4338